Cel-Sci Corporation Common Stock (CVM)

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

CVM stock results show that CEL-SCI missed analyst estimates for earnings per share the third quarter of 2024.

CEL-SCI just reported results for the second quarter of 2024.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

CEL-SCI Corporation shares are trading lower by 13.9% Friday morning. The company priced an offering of 3.875 million shares.

CEL-SCI just reported results for the fourth quarter of 2023.

Cel-Sci announces public offering of 16.13M shares at $0.31 per share, aiming to raise $5M for Multikine development and general purposes.

U.S. stock futures declined on Monday after ending lower on Friday. All four index futures slipped in trade.

CEL-SCI shares are trading higher by 18.6% during Wednesday's session. The company received positive feedback from the FDA regarding their cancer immunotherapy.